Matthew H. Abramson, MD
Nephrologist and educator, sharing free tools for kidney medicine.
Associate Professor of Medicine (Nephrology), Icahn School of Medicine at Mount Sinai
Free tools
For medical students, nephrology trainees and faculty.
- NephroResourceCalculators, CKD drug dosing, clinical trials, guidelines and interactive algorithms for clinicians.nephroresource.com
- NephToxA citation-grounded onco-nephrology atlas of how cancer therapies injure the kidney.nephtox.com
- miniNephronA mobile learning companion to NephroResource.mininephron.com
About
Dr. Abramson works across general nephrology and co-leads an onco-nephrology program, caring for people with kidney complications of cancer and its treatment. He is board certified in internal medicine and nephrology and a member of the American Society of Nephrology.
Training
- MD, St. George's University2014
- Internal medicine residency, Stony Brook Medicine2017
- Nephrology fellowship, Weill Cornell Medicine2019
- Onco-nephrology sub-fellowship, Memorial Sloan Kettering Cancer Center2020
Focus areas
- General nephrologyAKI, CKD, glomerular disease, hyponatremia, kidney stones and dialysis
- Onco-nephrologyCancer-therapy kidney injury (cisplatin, dasatinib), kidney disease after allogeneic stem cell transplantation, and paraprotein disease, including myeloma cast nephropathy and immunotactoid glomerulopathy
- EducationNephrology teaching and free clinical tools for trainees and clinicians
Selected publications
- 2026Shincovich CI, Chewcharat A, Adomi M, et al., including Abramson MH. Plasma exchange and daratumumab for myeloma cast nephropathy. Am J Hematol. PubMed doi:10.1002/ajh.70516
- 2025Gupta S, Glezerman IG, Hirsch JS, et al., including Abramson MH. Intravenous magnesium and cisplatin-associated acute kidney injury. JAMA Oncol. PubMed doi:10.1001/jamaoncol.2025.0756
- 2025Abramson MH, Sathick IJ, Knezevic A, et al. Changes in microbiome in patients with kidney injury after allogeneic hematopoietic stem cell transplantation. Kidney360. PubMed doi:10.34067/KID.0000000627
- 2024Abramson M, Shaikh A. Immunotactoid glomerulopathy. Adv Kidney Dis Health. PubMed doi:10.1053/j.akdh.2024.03.003
- 2024Gupta S, Glezerman IG, Hirsch JS, et al., including Abramson MH. Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study. BMJ. PubMed doi:10.1136/bmj-2023-077169
- 2023Adegbite BO, Abramson MH, Gutgarts V, et al. Patient-specific pharmacokinetics and dasatinib nephrotoxicity. Clin J Am Soc Nephrol. PubMed doi:10.2215/CJN.0000000000000219
- 2022Abramson M, Mehdi A. Hematological malignancies and the kidney. Adv Chronic Kidney Dis. PubMed doi:10.1053/j.ackd.2022.02.003
- 2021Abramson M, Yu SM, Campbell KN, et al. IgA nephropathy after SARS-CoV-2 vaccination. Kidney Med. PubMed doi:10.1016/j.xkme.2021.05.002
- 2021Abramson MH, Gutgarts V, Zheng J, et al. Acute kidney injury in the modern era of allogeneic hematopoietic stem cell transplantation. Clin J Am Soc Nephrol. PubMed doi:10.2215/CJN.19801220
Full list on ORCID.
Talks and media
- 2023
ASN Kidney Week, abstract
"One-Year Experiences of an Onconephrology Outpatient Clinic in New York," Maheshwari R, Abramson MH, Deshpande PP. J Am Soc Nephrol. 2023;34(11S). DOI
- 2023
The Fellow on Call podcast, Episode 050, March
Guest on "#NephMadness Onconephrology: ICI-Associated AKI and Chemotherapy-Related Hypomagnesemia." Episode
- 2023
#NephMadness, Onconephrology Region
Selection Committee member and region expert. AJKD Blog
- 2021
CJASN podcast, September 7
Discusses his study, "Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation." Podcast
- 2019
Memorial Sloan Kettering Onco-Nephrology Symposium, December 7
Abstract presentation, "Acute Kidney Injury in Hematopoietic Stem Cell Transplantation." Program
- 2018
ASN Kidney Week, poster SA-PO227
Trainee case report: "Plasmablastic Lymphoma Associated with IgD Lambda Light Chain Monoclonal Gammopathy and Severe AKI," Abramson M, Glezerman I. Abstract
KidneyCAN Town Hall, "Protecting Your Kidney Health"
Expert speaker with Hans Hammers, MD (UT Southwestern), on kidney health during kidney cancer treatment. KidneyCAN
Contact
For academic, speaking, and collaboration inquiries.